Life Science

AMC-AA is one of several fatty acid amides which can be used to measure FAAH activity. Exposure of AMC-AA to FAAH results in the release of the fluorescent aminomethyl coumarin that absorbs at 360 nm and emits at 465 nm, allowing for fast and

Steptavidin, a bacterial protein isolated from Streptomyces avidinii, is similar to egg-white avidin in its ability to bind biotin, and has been used as a replacement for egg-white avidin because of its more favorable chemical properties. Conjugates

Blocks the cell surface binding of the CXCR4 ligand CXCL12 (IC50 = 18 nM), inhibits calcium mobilization (IC50 = 4 nM), and (at 6,250 nM) completely blocks chemotaxis of SupT1 cells active against various HIV strains (IC50s = 6-12 nM).

Blocks the cell surface binding of the CXCR4 ligand CXCL12 (IC50 = 18 nM), inhibits calcium mobilization (IC50 = 4 nM), and (at 6,250 nM) completely blocks chemotaxis of SupT1 cells active against various HIV strains (IC50s = 6-12 nM).

Blocks the cell surface binding of the CXCR4 ligand CXCL12 (IC50 = 18 nM), inhibits calcium mobilization (IC50 = 4 nM), and (at 6,250 nM) completely blocks chemotaxis of SupT1 cells active against various HIV strains (IC50s = 6-12 nM).

A multikinase inhibitor that predominantly targets receptor tyrosine kinases, including VEGFR1, VEGFR2, VEGFR3, c-Kit, PDGFR, and RET (IC₅₀s = 2, 3, 6, 8, 84, and 59 nM, respectively) blocks VEGF-induced angiogenesis in the rat corneal

A multikinase inhibitor that predominantly targets receptor tyrosine kinases, including VEGFR1, VEGFR2, VEGFR3, c-Kit, PDGFR, and RET (IC₅₀s = 2, 3, 6, 8, 84, and 59 nM, respectively) blocks VEGF-induced angiogenesis in the rat corneal

A multikinase inhibitor that predominantly targets receptor tyrosine kinases, including VEGFR1, VEGFR2, VEGFR3, c-Kit, PDGFR, and RET (IC₅₀s = 2, 3, 6, 8, 84, and 59 nM, respectively) blocks VEGF-induced angiogenesis in the rat corneal

A multikinase inhibitor that predominantly targets receptor tyrosine kinases, including VEGFR1, VEGFR2, VEGFR3, c-Kit, PDGFR, and RET (IC₅₀s = 2, 3, 6, 8, 84, and 59 nM, respectively) blocks VEGF-induced angiogenesis in the rat corneal

A selective Aurora kinase inhibitor (IC₅₀s = 5, 4, and 1 nM for Aurora A, B, and C, respectively) inhibits the proliferation of 26 different tumor cell lines in vitro and is broadly active in multiple xenograft models.

A selective Aurora kinase inhibitor (IC₅₀s = 5, 4, and 1 nM for Aurora A, B, and C, respectively) inhibits the proliferation of 26 different tumor cell lines in vitro and is broadly active in multiple xenograft models.

A selective Aurora kinase inhibitor (IC₅₀s = 5, 4, and 1 nM for Aurora A, B, and C, respectively) inhibits the proliferation of 26 different tumor cell lines in vitro and is broadly active in multiple xenograft models.